Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Intellectual Property Watch

Intellectual Property Law

: Intellectual Property Watch

Inside Views: The Biosimilars Pathway: An Invitation To Litigation

By Intellectual Property Watch

Lynn C. Tyler writes: The litigation provisions of the recently-enacted legislation establishing a pathway to bring biosimilars to market contain ?patent? ambiguities in key areas, particularly whether the various lists of patents to be litigated are exclusive. Courts will have to resolve these issues over the next several years, likely at great (and unnecessary) expense and uncertainty to litigants.

Related Articles:

• New US Senate Patent Reform Bill Brings Many Reactions
• Advisory Group: ?Near Perfect Storm? Coming On Gene Patents In The US
• Biotech Legislative Agenda: Healthcare, Energy, Patents And Capital

Full post as published by Intellectual Property Watch on June 11, 2010 (boomark / email).